SCHEMBL7957403

SCHEMBL7957403

Cc1ccc(N2CCN(CCCc3nn(C)c4c3CCCC4)CC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HRH1 P35367 2/20 0.43
ADRA1D P25100 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
HTR7 P34969 2/20 0.41
ADRA2A P08913 1/20 0.41
HRH3 Q9Y5N1 1/20 0.40
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SIGMAR1 Q99720 2/20 0.40
L3MBTL3 Q96JM7 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A3 Q01959 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7959986 0.89 HTR1A (0.51) HRH1HRH3SIGMAR1SLC6A3HTR1A
SCHEMBL7959536 0.89 SIGMAR1 (0.52) HRH1HTR7KDM4ESIGMAR1HTR1A
SCHEMBL7959137 0.89 SIGMAR1 (0.53) HRH1ADRA1DADRA1AADRA1BHTR7
SCHEMBL7963943 0.85 MAPT (0.50) MAPTNPSR1HTR7MEN1KMT2A
SCHEMBL5776790 0.80 MAPT (0.45) MAPTNPSR1HRH1ADRA1DADRA1A
SCHEMBL7963946 0.79 MAPT (0.46) MAPTNPSR1HRH1ADRA1DADRA1A
SCHEMBL7963930 0.77 SIGMAR1 (0.53) HRH1HTR7SIGMAR1HTR1ADRD2
SCHEMBL5775439 0.75 MAPT (0.45) MAPTNPSR1HRH1ADRA1DADRA1A
SCHEMBL5776218 0.75 DRD4 (0.49) NPSR1HRH1HTR7HRH3ALDH1A1
SCHEMBL5775029 0.74 MAPT (0.44) MAPTNPSR1HRH1ADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP claimed
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed